Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease
AUTOR(ES)
DosReis, G.A.
FONTE
Brazilian Journal of Medical and Biological Research
DATA DE PUBLICAÇÃO
2011-02
RESUMO
Infection with the protozoan parasite Trypanosoma cruzi leads to Chagas disease, which affects millions of people in Latin America. Infection with T. cruzi cannot be eliminated by the immune system. A better understanding of immune evasion mechanisms is required in order to develop more effective vaccines. During the acute phase, parasites replicate extensively and release immunomodulatory molecules that delay parasite-specific responses mediated by T cells. This immune evasion allows the parasite to spread in the host. In the chronic phase, parasite evasion relies on its replication strategy of hijacking the TGF-β signaling pathway involved in inflammation and tissue regeneration. In this article, the mechanisms of immune evasion described for T. cruzi are reviewed.
Documentos Relacionados
- Integrate Study of a Bolivian Population Infected by Trypanosoma cruzi, the Agent of Chagas Disease
- Natural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure.
- Mechanism of Action of 4-Phenoxyphenoxyethyl Thiocyanate (WC-9) against Trypanosoma cruzi, the Causative Agent of Chagas’ Disease†
- Humoral and Cellular Immune Responses to Trypanosoma cruzi-Derived Paraflagellar Rod Proteins in Patients with Chagas' Disease
- Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease
